ELUT ▼ -1.3% - Elutia Inc. $ELUT - Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch 05-NOV-2026 04:17 PM ET